Sale!

ETANERCEPT 25MG

Name: ETANERCEPT 25MG
Brand: INTAS PHARMACEUTICALS LTD
SKU: 1634
Availability: InStock

2-8* C

ETANERCEPT 25MG

MRP	:	~~MRP ₹5,356.88~~
Price	:	₹2,400.00
You Save	:	₹2,956.88 (55.2%)

1 Prefilled Syringe

SKU: 1634 Categories: Anti-Cancer, Anti-Cancer Drugs Tags: Anti cancer, Anti-Cancer Drug Brand: INTAS PHARMACEUTICALS LTD

Etacept 25mg Injection is used to treat the following:

Rheumatoid arthritis
Plaque psoriasis
Psoriatic arthritis
Ankylosing spondylitis
Juvenile idiopathic arthritis
Non-radiographic axial spondyloarthritis

Etacept 25mg Injection's mechanism of action involves its role as a tumor necrosis factor (TNF) inhibitor. By binding to circulating TNF-alpha and acting as a decoy receptor, this medication disrupts the inflammatory signaling pathway, suppressing immune cell activation and reducing the production of inflammatory cytokines. This neutralization of TNF-alpha effectively mitigates inflammation, making it highly effective.

Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Etacept 25mg Injection, reducing effectiveness by causing undesirable side effects.

Etacept 25mg Injection can be administered via subcutaneous injection and intravenous infusion. The choice of administration route depends on the patient's condition, preferences, and the healthcare provider's recommendation, both of which have been proven effective in treating autoimmune diseases.

Store at room temperature, between 36°F to 46°F (2°C to 8°C)
Keep away from moisture, heat, and light.
It should not be frozen.
Keep away from children and pets.

Serious:

Serious infections
Tuberculosis (TB) reactivation
Hepatitis B reactivation
Neurological events
Allergic reactions

Common:

Injection site reactions
Upper respiratory infections
Headache
Nausea

Etacept 25mg Injection increases the risk of serious infections, including tuberculosis and hepatitis B reactivation, and may lead to neurological events. Patients with a history of malignancy, heart failure, autoimmune disorders, or liver impairment should be closely monitored. Live vaccines should be avoided, and non-live vaccines may have reduced efficacy. Use in pregnant and breastfeeding women should be carefully considered. This medication should not be combined with other biological therapies. Close monitoring and prompt reporting of adverse reactions are essential for safe and effective treatment. Patients scheduled for surgery may need to discontinue the drug temporarily. Regular screening and communication with healthcare providers are vital to managing potential risks and optimizing treatment outcomes.

ETANERCEPT 25MG

Fact Box of ETANERCEPT 25MG

Disclaimer

2000+ products

Secure Payment

Easy Return

Company

Speciality Drugs

More Info

ETANERCEPT 25MG

Cold Chain Logistics

Salt Composition

INTAS PHARMACEUTICALS LTD

Fact Box of ETANERCEPT 25MG

Disclaimer

2000+ products

Secure Payment

Easy Return